NCT05395936

Brief Summary

The purpose of this research study is to measure tissue temperatures and generate a prospective database of participants undergoing mastectomy with or without breast reconstruction at Wake Forest Baptist Hospital (WFBH) in order to enable and facilitate the evaluation of important and novel research questions - and quality improvement (QI) ideas/objectives - that may improve the care of breast surgery patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 27, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

September 29, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 17, 2024

Completed
9 months until next milestone

Results Posted

Study results publicly available

December 4, 2024

Completed
Last Updated

December 4, 2024

Status Verified

November 1, 2024

Enrollment Period

1.5 years

First QC Date

May 24, 2022

Results QC Date

October 21, 2024

Last Update Submit

November 26, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of Women Consenting to Have Mastectomy Flap Temperatures Measured During Surgery

    This will be computed by the dividing the total number of eligible women screened by the number of women who consent.

    90 days post surgery

  • Number of Women Having All Relevant Flap Temperatures Measured

    This will either be 12 or 24 total expected flap temperatures: 4 quadrants, at three time points- pre and post-mastectomy and pre-implant placement; one or both breasts), and we will compute a 95% confidence interval.

    90 days post surgery

Secondary Outcomes (1)

  • Change in Mastectomy Flap Temperatures and Core Body Temperatures

    At pre-mastectomy (baseline), pre-implant (before surgery) and post mastectomy (up to 90 days post surgery)

Study Arms (1)

Intraoperative Data Collection Arm

EXPERIMENTAL

Participants scheduled for mastectomy with or without breast reconstruction during the course of their breast surgery treatment will have breast skin temperatures taken using a myocardial probe in different anatomical breast areas at multiple time points during the surgery.

Other: Myocardial Probe Temperature ScreenOther: Data Collection

Interventions

The myocardial probe is a needle that measures temperatures. The skin site for introducing the myocardial probe will be small enough that participants will not notice that temperatures have been collected. If participants have multiple operations, temperatures may be collected at each operation.

Intraoperative Data Collection Arm

Study team members will collect medical history and other information to potentially understand the safety and success of breast surgery better to allow investigators to identify variables, or changes to help understand investigators roles in potential complications in breast surgery.

Intraoperative Data Collection Arm

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for unilateral or bilateral mastectomy with implant based breast reconstruction within the Wake Forest Baptist Health System.
  • Aged 18 or older.
  • Ability to understand an IRB-approved informed consent document (either directly or via a legally authorized representative).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Results Point of Contact

Title
Adam Katz
Organization
Atrium Health Wake Forest Baptist Comprehensive Cancer Center

Study Officials

  • Adam Katz, MD

    Wake Forest Baptist Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2022

First Posted

May 27, 2022

Study Start

September 29, 2022

Primary Completion

March 17, 2024

Study Completion

March 17, 2024

Last Updated

December 4, 2024

Results First Posted

December 4, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations